Stem Cells to Treat Unborn Babies with Debilitating Genetic Disease
In a preemptive approach to treat a debilitating genetic disease, scientists in Germany and the United States are planning clinical trials to use stem cell therapy to treat osteogenesis imperfecta (OI) in ailing fetuses. Occurring in about one in 20,000 live births, OI is the result of a gene mutation that leads to a deficiency [Read More]